Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedSci Healthcare HoldingsHKSE:02415 -0.65%75 PS Ratio is 1.40 as of Sep. 13, 2026, which is 44% below its 10-year median of 2.52. GuruFocus rates HKSE:02415 with a GF Score™ of 75/100 and a GF Value™ of HK$1.43 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 661 Healthcare Providers & Services companies, MedSci Healthcare Holdings ranks better than 51.89% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, MedSci Healthcare Holdings's share price is HK$0.76.
MedSci Healthcare Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.54. Hence, MedSci Healthcare Holdings's PS Ratio for today is 1.40.
The historical rank and industry rank for MedSci Healthcare Holdings's PS Ratio or its related term are showing as below:
HKSE:02415'
s PS Ratio Range Over the Past 10 Years
Min: 0.9 Med: 2.52 Max: 20.19
Current: 1.4
During the past 6 years, MedSci Healthcare Holdings's highest PS Ratio was 20.19. The lowest was 0.90. And the median was 2.52.
HKSE:02415's PS Ratio is ranked better than 51.89% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.47
vs HKSE:02415: 1.40
During the past 6 years, MedSci Healthcare Holdings's highest 3-Year average Revenue per Share Growth Rate was 20.50% per year. The lowest was -5.30% per year. And the median was -5.00% per year.
MedSci Healthcare Holdings (HKSE:02415) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
MedSci Healthcare Holdings PS Ratio Related Terms
MedSci Healthcare Holdings PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02415 vs VEEV, BTSG, TEM: PS Ratio Comparison
For the Health Information Services subindustry, MedSci Healthcare Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedSci Healthcare Holdings PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedSci Healthcare Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where MedSci Healthcare Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
MedSci Healthcare Holdings's Share Price of today is HK$0.76.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MedSci Healthcare Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
MedSci Healthcare Holdings (HKSE:02415) has a PS Ratio of 1.40 as of Sep. 13, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MedSci Healthcare Holdings and its competitors. This is 44% below median its historical median of 2.52. Over the past decade, MedSci Healthcare Holdings' PS Ratio has ranged from 0.90 to 20.19. According to the industry distribution chart, MedSci Healthcare Holdings ranks #318 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 48.1%.
Is MedSci Healthcare Holdings' PS Ratio too high?
MedSci Healthcare Holdings' current PS Ratio of 1.40 is 44% below median its 10-year median of 2.52. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 20.19. The Healthcare Providers & Services industry median PS Ratio is 1.47. MedSci Healthcare Holdings' value of 1.40 is 4.8% below this industry median. Based on the distribution chart, MedSci Healthcare Holdings ranks #318 out of 661 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, MedSci Healthcare Holdings has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does MedSci Healthcare Holdings' PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedSci Healthcare Holdings ranks #318 out of 661 companies for PS Ratio. This puts MedSci Healthcare Holdings in the upper half of its industry. The industry median PS Ratio is 1.47. MedSci Healthcare Holdings' value of 1.40 is 4.8% below this benchmark. Historically, MedSci Healthcare Holdings' own PS Ratio has ranged from 0.90 to 20.19 over the past decade. While the company's 10-year median is 2.52 vs. the industry median of 1.47, MedSci Healthcare Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.47, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedSci Healthcare Holdings's current PS Ratio of 1.40 is 4.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on MedSci Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedSci Healthcare Holdings's current PS Ratio is 1.40, which is 44% below median its own 10-year median of 2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedSci Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, MedSci Healthcare Holdings (HKSE:02415) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.43, compared to a current price of HK$0.76 — trading 46.9% below its estimated fair value. The current PS Ratio is 1.40, which is 44% below median its 10-year median of 2.52 and 4.8% below the Healthcare Providers & Services industry median of 1.47. MedSci Healthcare Holdings' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For MedSci Healthcare Holdings (HKSE:02415), the current PS Ratio is 1.40 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedSci Healthcare Holdings (HKSE:02415) Overvalued in 2026?
Based on GuruFocus' analysis, MedSci Healthcare Holdings stock appears to be undervalued.
The current stock price of HK$0.76 is trading 46.9% below its estimated GF Value™ of HK$1.43.
GuruFocus considers MedSci Healthcare Holdings to be Possible Value Trap.
Key valuation signals for HKSE:02415:
PS Ratio: 1.40 (44% below median its 10-year median of 2.52)
GF Value™: HK$1.43 vs. price of HK$0.76 (46.9% below fair value)
Industry Position: 4.8% below the Healthcare Providers & Services median (#318 of 661)
No single metric tells the full story. See the HKSE:02415 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.
75GF Score
Get the complete analysis for HKSE:02415
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02415 has been successfully added to your 
